Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

mor growth inhibition in models of breast cancer, colorectal cancer, non-small cell lung cancer, and glioblastoma, and has been shown to cause substantial tumor regression in all models tested. Significantly, a single dose of XL880 completely inhibited tumor growth for 21 days in a glioblastoma model.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in Phase II and Phase I clinical development for cancer and renal disease. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Sankyo. For more information, please visit the company's web site at www.exelixis.com.

This press release contains forward-looking statements, including without limitation statements related to the potential efficacy of XL880. Words such as "suggest," "believes," "indicates," "should," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the potential failure of XL880 to demonstrate safety and efficacy in clinical testing. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis'
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/16/2009)... Incorporated (Nasdaq: ARAY ), a global leader in ... and chief executive officer, Euan S. Thomson, Ph.D., is ... Healthcare Conference in San Francisco on Wednesday, January 13, ... A live webcast of each presentation will be available ... Web site at http://www.accuray.com . The webcast ...
(Date:12/16/2009)... CLEVELAND, Dec. 16 DATATRAK International, ... company focused on global eClinical solutions for ... release of its version 9.0 eClinical Software. ... vision for product and service delivery and ... ONE,s Knowledge(TM) offering: the DATATRAK Learning Center(TM) ...
(Date:12/16/2009)... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an ... $1 million in 12% per annum short term debt ... an initial drawdown of $500,000, with accrued interest and ... $500,000 with accrued interest and principal repayable in one ... becoming cashflow positive for any calendar month prior to ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 1Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 1Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 3Lead Levels in Many Lipsticks Higher Than Reported 56053 1Lead Levels in Many Lipsticks Higher Than Reported 56053 2Lead Levels in Many Lipsticks Higher Than Reported 56053 3
... GROVE, Minn., Dec. 7 NeuroVasx, Inc. announced,today the completion ... $8,500,000 with MJSK of Minneapolis, MN and the Stephens Group ... The company also announced completion of long term follow ... in a clinical,study which was completed in May. The company ...
... Celldex also receives approval from Health Canada to ... collaboration with the National Cancer Institute, PHILLIPSBURG, ... the U.S. Food and Drug Administration (FDA) has,granted ... treatment of,EGFRvIII expressing Glioblastoma Multiforme (GBM). GBM is ...
Other Medicine Technology:Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 2Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 3Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 4Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 5
(Date:12/17/2009)... Physicians, nurses now able to access trusted medical information using ... ... Marlborough, MA (PRWEB) December 17, 2009 -- Skyscape, Inc., the ... devices and the Internet, has launched a mobile clinical decision ... resources are now available on most smart phone devices, making ...
(Date:12/17/2009)... NEW YORK, Dec. 17 Reportlinker.com ... is available in its catalogue: ,, ... designed to provide the animal health industry ... and insight, critical to the development and ... The study,s major objectives include: ,, ...
(Date:12/17/2009)... Dec. 17 Today, CDC,s Morbidity and ... that the number of state-level epidemiologists has decreased ... over 10% since 2006. There was also a ... same period, including epidemiology capacity for bioterrorism and ... areas such as occupational health, substance abuse, and ...
(Date:12/17/2009)... Ohio, Dec. 17 Good Samaritan Hospital is ... health issues with the launch of the Good Samaritan ... The center is designed to help treat two common ... and slippage of the bladder, uterus or rectum (pelvic ... degree of urinary leakage and one out of three ...
(Date:12/17/2009)... SEIU ULTCW (United Long Term Care Workers, Union) ... providers have overwhelmingly voted in favor of a ... layers of protection to the current homecare provider ... additional contract improvements. ,, "As several Counties ... provider wages to as low as minimum wage, ...
Breaking Medicine News(10 mins):Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 3Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 4Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:New Alameda County IHSS Contract Sends Clear Message to Elected Leaders That Homecare Program Must Remain a California Priority 2
... glass a day may lower risk for Barrett,s, a precursor ... News) -- Drinking a glass of wine a day may ... esophageal cancer. , Barrett,s esophagus, which affects about 5 ... permanently damages the lining of the esophagus. People with this ...
... Americans stay awake worrying about personal finances , , MONDAY, March ... are tossing and turning, unable to get a good night,s ... or their money, a new poll finds. , Money ... Iraq and Afghanistan, global warming, or the threat of a ...
... in New Offices Registered for Attachment Services, EHG ... Attachment GrowthIRVINE, Calif., March 2 EDI Health ... streamlined technology and transaction solutions for patients, payers ... that it has been named the top clearinghouse ...
... Sebelius Sweeps Into Washington, Will Her High-Tax ... PROPOSING BILLIONS IN NEW TAXES, OBAMA ANNOUNCES ... The following was released today by the ... ) Today, President Obama Will Make ...
... Cart Allows Easier Operation and Improved Workflow for ... Inc., the pioneer and world leader in image ... designed system cart for the PercuNav interventional imaging ... # 322 of the Society of Interventional Radiology,s ...
... LCA-Vision Inc. (Nasdaq: LCAV ), a ... Plus (R) brand, today announced that members of its executive ... Institutional Investors Conference on Monday, March 9, 2009 at 8:40 ... The JW Marriott Grande Lakes Hotel in Orlando, Fla. ...
Other Medicine News:Health News:Wine May Be Protective Against Esophageal Cancer 2Health News:With the Economy Down, Sleeplessness Is Up 2Health News:With the Economy Down, Sleeplessness Is Up 3Health News:National Electronic Attachment (NEA) Names EDI Health Group Top Clearinghouse for 2008 2Health News:RNC: Wrong Prescription 2Health News:RNC: Wrong Prescription 3Health News:RNC: Wrong Prescription 4Health News:RNC: Wrong Prescription 5Health News:RNC: Wrong Prescription 6Health News:Traxtal to Introduce Next-Generation PercuNav System Cart at SIR Annual Scientific Meeting 2
New!...
... Electrical I/A unit for planned ... aspiration (foot control). Independent irrigation, suction, ... allows the surgeon to control all ... all functions simultaneously. Preset and actual ...
... Anterior and Posterior segment surgeries Vitrectomy-Lensectomy ... Ventury or Peristaltic Linear Aspiration. Interchangeable ... specific cutting action. Easy to read ... Cutting speed-variable from 1- 600 cuts ...
...
Medicine Products: